Paper highlight: New driver of T cell leukemia growth

Sep 20, 2010

NKX3.1, a protein that suppresses the development of prostate tumors, promotes the growth of a different type of tumor in the blood, according to an article published online on September 20 in the Journal of Experimental Medicine.

Paul-Henri Romeo and colleagues find that TAL1, a abundantly expressed in approximately 40% of patients with T cell acute lymphoblastic leukemia (T-ALL), drives expression of NKX3.1. Eliminating NKX3.1 halted the growth of TAL1-expressing T-ALL cells in culture and after injection into mice.

It's not yet clear how NKX3.1 sustains the growth of T-ALL cells, but these findings show that this protein can either halt or hasten tumor development depending on the tissue environment.

Explore further: Unplanned hospitalizations with GI cancer patients common

More information: Kusy, S., et al. 2010. J. Exp. Med. doi:10.1084/jem.20100745. http://www.jem.org/

add to favorites email to friend print save as pdf

Related Stories

Targeted Immune Cells Shrink Tumors in Mice

Feb 10, 2009

(PhysOrg.com) -- Researchers have generated altered immune cells that are able to shrink, and in some cases eradicate, large tumors in mice. The immune cells target mesothelin, a protein that is highly expressed, or translated ...

Strengthening the tumor-fighting ability of T cells

Mar 24, 2008

Researchers may have found a new way to promote immune cell attack on tumors. The new study, by a team of scientists in Milan, Italy, will be published online on March 24 in the Journal of Experimental Medicine.

Recommended for you

Blood biomarker may detect lung cancer

6 hours ago

A new study shows that patients with stage I to stage III non-small cell lung cancer have different metabolite profiles in their blood than those of patients who are at risk but do not have lung cancer. The study abstract ...

ACG: Recent increase in incidence of young-onset CRC

22 hours ago

(HealthDay)—The incidence of young-onset colorectal cancer (CRC) is increasing, and the disease is more aggressive pathologically. These findings are being presented at the annual meeting of the American ...

User comments : 0